Antihypertensive drug class and impaired fasting glucose: a risk association study among Chinese patients with uncomplicated hypertension

Table 3 The crude hazard ratios of having above borderline and adverse glucose profiles for each antihypertensive drug group

	Bivariate Analysis Crude Odds Ratios for above borderline results (95% C.I.) (≥ 6.1 mmol/l)	p value	Bivariate Analysis Crude Odds Ratios for adverse results (95% C.I.) (≥ 7.0 mmol/l)	p value
(1). β-blockers	0.881 (0.586, 1.323)	0.540	0.993 (0.459, 2.150)	0.986
(2). Thiazide Diuretics	0.860 (0.530, 1.397)	0.543	0.828 (0.316, 2.168)	0.700
(3). CCB	0.604 (0.390, 0.933)	0.022	1.043 (0.494, 2.204)	0.911
(4). RAS	0.720 (0.280, 1.850)	0.493	1.944 (0.572, 6.607)	0.278

(CCB: Calcium channel blockers; RAS: drugs acting on the rennin angiotensin system. Glucose levels for desirable: ≤ 6.0 mmol/l, above borderline: ≥ 6.1 mmol/l; adverse: ≥ 7.0 mmol/l. The desirable group was used as the reference)